Using the seven functionally-altered genes to predict HCC patient survival, we found that HCC samples with TRMT10C, YTHDF1 and YTHDC1 gene mutations had worse prognosis than samples without mutations. This evidence concerns the gene YTHDF1 and hepatocellular carcinoma.